Prenetics Global (PRE) Registration filing summary

Management team and governance

• CEO and Chairman is Danny Sheng Wu Yeung, who signed the filing as principal executive officer.

• Chief Financial Officer is Lo Hoi Chun, also principal financial and accounting officer.

• Board includes independent directors Yin Pan Cheng, Darshan Ravindra Shah, and Hudson Blake Leogrande.

• U.S. authorized representative is Cogency Global Inc., signed by Colleen A. De Vries, Senior Vice President.

Offering details and pricing

• Registration statement filed as a pre-effective amendment to Form F-1 for a public offering of securities.

• Securities may be offered on a delayed or continuous basis under Rule 415.

• No underwriters involved in recent private placements of shares and warrants.

Risk factors and disclosures

• Indemnification of directors and officers provided to the maximum extent permitted by Cayman Islands law, except for fraud or willful default.

• SEC notes indemnification for Securities Act liabilities is unenforceable as against public policy.